Sign Out
During short-term therapy (less than 1 month) 7.0% of patients have side effects: nausea (1.3%), abdominal pain (1.2%), headache (1%), dyspepsia (0.7%).
More frequently occurring side effects (16.2%) have been observed in patients receiving prolonged (approximately 1 month) treatment, most of which had major underlying pathology and multiple concomitant medications.
Side effects relating to the gastro-intestinal tract are 6.1%, in which nausea (2%) and epigastric pain (0.9%).
Some cases of hypokalemia during long-term treatment have been observed.
